1. Home
  2. TLSI vs RCKY Comparison

TLSI vs RCKY Comparison

Compare TLSI & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • RCKY
  • Stock Information
  • Founded
  • TLSI 2010
  • RCKY 1932
  • Country
  • TLSI United States
  • RCKY United States
  • Employees
  • TLSI N/A
  • RCKY N/A
  • Industry
  • TLSI Medical Specialities
  • RCKY Shoe Manufacturing
  • Sector
  • TLSI Health Care
  • RCKY Consumer Discretionary
  • Exchange
  • TLSI Nasdaq
  • RCKY Nasdaq
  • Market Cap
  • TLSI 150.3M
  • RCKY 168.0M
  • IPO Year
  • TLSI N/A
  • RCKY 1993
  • Fundamental
  • Price
  • TLSI $4.93
  • RCKY $24.17
  • Analyst Decision
  • TLSI Strong Buy
  • RCKY Hold
  • Analyst Count
  • TLSI 6
  • RCKY 2
  • Target Price
  • TLSI $11.75
  • RCKY $24.50
  • AVG Volume (30 Days)
  • TLSI 33.1K
  • RCKY 35.1K
  • Earning Date
  • TLSI 11-14-2024
  • RCKY 02-26-2025
  • Dividend Yield
  • TLSI N/A
  • RCKY 2.56%
  • EPS Growth
  • TLSI N/A
  • RCKY 28.46
  • EPS
  • TLSI N/A
  • RCKY 1.78
  • Revenue
  • TLSI $26,891,000.00
  • RCKY $451,670,000.00
  • Revenue This Year
  • TLSI $60.96
  • RCKY N/A
  • Revenue Next Year
  • TLSI $53.65
  • RCKY $3.97
  • P/E Ratio
  • TLSI N/A
  • RCKY $13.55
  • Revenue Growth
  • TLSI 67.90
  • RCKY N/A
  • 52 Week Low
  • TLSI $3.50
  • RCKY $19.65
  • 52 Week High
  • TLSI $10.42
  • RCKY $40.14
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 56.22
  • RCKY 60.82
  • Support Level
  • TLSI $4.53
  • RCKY $21.75
  • Resistance Level
  • TLSI $4.92
  • RCKY $23.49
  • Average True Range (ATR)
  • TLSI 0.29
  • RCKY 0.92
  • MACD
  • TLSI -0.02
  • RCKY 0.16
  • Stochastic Oscillator
  • TLSI 50.63
  • RCKY 88.97

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About RCKY Rocky Brands Inc.

Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract. It generates majority of the revenue from Wholesale segment.

Share on Social Networks: